Episode Details

Back to Episodes

EARNINGS — Around the Horn: LLY, MRK, ALGN, HSY

Published 3 weeks ago
Description
Eli Lilly (Hannah): revenue $24.397B (+39%), non-GAAP EPS $7.48, Mounjaro $10.723B (+65%), Zepbound $5.352B (+49%), FY revenue guide raised to $91-92B. Reaction +4.09% — fair. Merck (Hannah): non-GAAP EPS $2.49, worldwide sales $18.086B (+5%); the $2.77-2.82 FY guide embeds $6.05/sh of one-time charges — read the footnote, plus ~$550M pull-forward quality note. Reaction +2.17% — fair. Align (Hannah): revenue $999.7M (+1.8%), small beat; FY guide CUT to $4.11-4.13B; CEO Hogan steps down Dec 31, 2026, Jennifer Davis succeeds. Reaction +0.90% — fair for now. Hershey (Stan): adj EPS $2.64 vs $2.11 (+25%), guide raised; price +11 pts / volume -10 pts bridge, cocoa relief arriving. Reaction -2.45% — the volume bill, charged fairly. All figures primary-release verified. This information is for informational purposes only. This is not financial advice. Please do your own research.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us